Sign in

NCT05611697Recruiting

Laparoscopic Single Anastomosis Sleeve Ileal Bypass Versus Laparoscopic Sleeve Gastrectomy for Morbid Obesity

Laparoscopic Single Anastomosis Sleeve Ileal Bypass Versus Laparoscopic Sleeve Gastrectomy for Morbid Obesity: A Randomized Trial

Source: ClinicalTrials.gov · Last updated 18 May 2026

Brief summary (registry, in English)

This study will compare two bariatric surgical interventions in terms of weight loss, gastroesophageal reflux, and effects on obesity-related comorbid conditions in morbidly obese patients.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
220 (estimated)
First submitted
9 May 2022
Start date
17 Feb 2023
Primary completion date
Dec 2028
Lead sponsor
Oslo University Hospital
Diseases
Obesity
NCT number
NCT05611697

What you commit to

  • Study type: Interventional
  • Planned participants: 220
  • From 17 Feb 2023 to the primary completion date, Dec 2028
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Previous or current gastroesophageal reflux symptoms with daily use of antireflux medication. Patients are also excluded if preoperative manometry identifies a hiatal hernia (≥4cm in axial length) or if preoperative upper endoscopy identifies esophagitis grade C or D (LA classification), peptic stricture, Barrett's esophagus, or esophageal carcinoma.

Other illness

  • A history of major abdominal or bariatric surgery (excluding appendectomy, cholecystectomy, and sectio).
  • Established disabling cardiopulmonary disease, ongoing treatment for cancer, long-term steroid use, and conditions believed to be associated with poor adherence after surgery.

Other

  • BMI ≥55 kg/m2.
  • Achalasia
  • Pregnancy.

Who the study is looking for

  • Morbid obesity at referral for bariatric surgery (i.e. a body-mass index \[BMI\] of ≥35 kg/m2 with obesity-related comorbid conditions or ≥40 kg/m2 with or without such comorbidities).
  • Age 20-60 years.
  • Previous failed attempts of weight loss.
  • Norwegian speaking patients.

Age in the registry: 20 years to 60 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Oslo University Hospital
Coordinator of this site? Confirm its status
OsloNorwayRecruiting
The Morbid Obesity Center, Vestfold Hospital Trust
Coordinator of this site? Confirm its status
TønsbergNorwayRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.